Dataset: KrasG12D partially compensates for the loss of beta-catenin in MLL-AF9 AML
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in MLL-AF9 AML. We evaluated the dependance on beta-...
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in MLL-AF9 AML. We evaluated the dependance on beta-catenin for KrasG12DMLL-AF9 leukemia. Lin-Kit+ bone marrow cells obtained from mice transplanted with primary MLL-AF9 leukemia cells and KRasG12DMLL-AF9 leukemia cells were assessed for gene expression in the presence or absence of beta-catenin
- Species:
- mouse
- Samples:
- 12
- Source:
- E-GEOD-49248
- PubMed:
- 24189294
- Updated:
- Dec.12, 2014
- Registered:
- Nov.12, 2014
Factors:
(via ArrayExpress)
| Sample |
|---|
| GSM1195957 1 |
| GSM1195963 1 |
| GSM1195964 1 |
| GSM1195965 1 |
| GSM1195966 1 |
| GSM1195967 1 |
| GSM1195968 1 |
| GSM1195969 1 |
| GSM1195970 1 |
| GSM1195971 1 |
| GSM1195972 1 |
| GSM1195973 1 |